Barriers To Prescribing Targeted Therapies For Nsclc Patients With Highly Actionable Gene Variants In The Va National Precision Oncology Program.

Vishal Vashistha,Jenna Armstrong,David Winski,Meghan Price,Bradley J. Hintze,Pradeep Poonnen,Jane Snowdon,Gretchen Purcell Jackson,Dilhan Weeraratne,David Brotman,Neil L. Spector,Michael J. Kelley

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 1|浏览19

暂无评分

摘要

2005Background: Next-Generation Sequencing (NGS) gene panels are often completed to guide therapeutic decisions for patients with advanced stage non-small cell lung cancer (NSCLC). Patients with hi...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要